New melanoma drug Zelboraf nearly doubles survival in majority of patients
Wednesday, February 22, 2012 - 17:00
in Health & Medicine
Investigators from Vanderbilt-Ingram Cancer Center (VICC) and 12 other centers in the United States and Australia have found that a new drug for patients with metastatic melanoma nearly doubled median overall survival.